{"id":487,"text":"Academic Editor: Roja Rahimi The worldwide using of herb products and the increasing potential herb-drug interaction issue has raised enthusiasm on discovering the underlying mechanisms.","label":[],"Comments":[]}
{"id":488,"text":"Previous review indicated that the interactions may be mediated by metabolism enzymes and transporters in pharmacokinetic pathways.","label":[],"Comments":[]}
{"id":489,"text":"On the other hand, an increasing number of studies found that genetic variations showed some influence on herb-drug interaction effects whereas these genetic factors did not draw much attention in history.","label":[[62,80,"Parameter"],[150,165,"Parameter"]],"Comments":[]}
{"id":490,"text":"We highlight that pharmacogenomics may involve the pharmacokinetic or pharmacodynamic pathways to affect herb-drug interaction.","label":[],"Comments":[]}
{"id":491,"text":"We are here to make an updated review focused on some common herb-drug interactions in association with genetic variations, with the aim to help safe use of herbal medicines in different individuals in the clinic.","label":[[20,37,"Study"],[104,122,"Parameter"]],"Comments":[]}
{"id":492,"text":"Herbal medicinal products (HMPs) belong to a main part of complementary and alternative medicine (CAM).","label":[[0,32,"Herb name"]],"Comments":[]}
{"id":493,"text":"The National Center for Complementary and Alternative Medicine (NCCAM) has defined CAM as those health care practices not currently considered an integral part of conventional medicine [1].","label":[],"Comments":[]}
{"id":494,"text":"During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment.","label":[[7,27,"Duration"]],"Comments":[]}
{"id":495,"text":"It was estimated that in 1990 about one-third of the US population used unconventional therapies and the expenditures on this amount to $13.7 billion [2], whereas in 2007 approximately 38 percent of American adults (83 million) are using some form of CAM for their health, and the expenditures reached $34 billion [1].","label":[[199,207,"Ethnic group"]],"Comments":[]}
{"id":496,"text":"Correspondingly the funding for NCCAM has reached $124.125 million in 2013, much more than that was in 1998 ($19.5 million) when it was established [1].","label":[],"Comments":[]}
{"id":497,"text":"In eastern Asia, countries that have a tradition use of oriental herb medicine for centuries, the prevalence of CAM use is much higher.","label":[[79,92,"Duration"]],"Comments":[]}
{"id":498,"text":"In Japan, the use of CAM in the general population had been reported to be 76% [3].","label":[],"Comments":[]}
{"id":499,"text":"In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4].","label":[[19,25,"Pathology"]],"Comments":[]}
{"id":500,"text":"In South Korean population reported a range from 29% to 83% [5].","label":[[3,15,"Ethnic group"]],"Comments":[]}
{"id":501,"text":"The prevalence of HMPs and other forms of CAM for treatment have its reasons.","label":[[18,22,"Herb name"]],"Comments":[]}
{"id":502,"text":"Conventional medicines are relatively more expensive, more difficult, and inconvenience of access and sometimes more likely to get side effects, toxicities, and incomplete efficacy.","label":[[131,143,"Pathology"],[145,155,"Pathology"]],"Comments":[]}
{"id":503,"text":"CAM, such as traditional Chinese medicine (TCM), though empirical, has been used for centuries and proved to be effective.","label":[[25,32,"Ethnic group"]],"Comments":[]}
{"id":504,"text":"In developing countries like China patients, especially those in rural areas, are more likely to choose HMPs as main medicine for treatment.","label":[[104,108,"Herb name"]],"Comments":[]}
{"id":505,"text":"In developed countries or areas like Japan, the increased use of CAM has promoted the government approval of 148 traditional Japanese (or Chinese) herbal medicines listed on the “National Health Insurance Drug Tariff” [6].","label":[[125,133,"Ethnic group"],[138,145,"Ethnic group"]],"Comments":[]}
{"id":506,"text":"Western countries, however, in most cases use herb prescriptions as dietary supplements or as part of a traditional medicine, and this trend is still rising.","label":[],"Comments":[]}
{"id":507,"text":"This increased the chance of concurrently use of herbs and conventional drugs.","label":[],"Comments":[]}
{"id":508,"text":"Similar to drug-drug interactions, the multicomponent herbs can exert their effects on pharmacokinetics and consequently lead to herb-drug interactions (HDIs) [7].","label":[[35,59,"Herb name"],[87,103,"Parameter"]],"Comments":[]}
{"id":509,"text":"Understanding the exact mechanism of each extract of an herb that affects drug's absorption, distribution, metabolism, and excretion (ADME) properties is incomplete at the moment.","label":[[74,150,"Parameter"]],"Comments":[]}
{"id":510,"text":"A review of previous studies indicated that pharmacogenetic factors may help to explain the HDIs effect and give us instructions for rational drug administration.","label":[[44,67,"Parameter"]],"Comments":[]}
{"id":511,"text":"The incidences of herb products to affect drug responses maybe more often in the clinic than expected for it is more easy for patients to conduct self-administration without informing their health care providers.","label":[],"Comments":[]}
{"id":512,"text":"Some of the interactions may have a beneficial effect by increasing drug efficacy or diminishing potential side effects.","label":[[68,81,"Parameter"],[107,119,"Pathology"]],"Comments":[]}
{"id":513,"text":"For example, combined therapy of garlic (250 mg\/kg) with captopril demonstrated higher synergistic action with respect to fall in blood pressure and ACE inhibition [8]; patients received silymarin (140 mg three times daily) in combination with conventional desferrioxamine therapy showed beneficial effects on thalassemia patients [9].","label":[[33,39,"Herb name"],[41,50,"Amount"],[57,66,"Drug"],[130,144,"Parameter"],[149,152,"Target"],[187,196,"Drug"],[198,204,"Amount"],[205,222,"Frequency"],[257,280,"Drug"],[310,321,"Pathology"]],"Comments":[]}
{"id":514,"text":"However, more often the potential side-effect and outcome influence may be brought about by combination use of HMPs and conventional drugs, and these circumstances are always difficult to predict.","label":[[34,45,"Pathology"],[111,115,"Herb name"]],"Comments":[]}
{"id":515,"text":"Previous studies identified various mechanisms of pharmacokinetic HDIs, mainly mediated by drug-metabolizing enzymes and transporters [10].","label":[],"Comments":[]}
{"id":516,"text":"For example, St. John's wort (Hypericum perforatum) significantly reduced the area under the plasma concentration-time curve (AUC) and blood concentrations of cyclosporine, midazolam, tacrolimus, amitriptyline, digoxin, indinavir, warfarin, phenprocoumon, and theophylline.","label":[[13,51,"Herb name"],[74,130,"Parameter"],[135,272,"Parameter"],[159,171,"Drug"],[173,182,"Drug"],[184,194,"Drug"],[196,209,"Drug"],[211,218,"Drug"],[220,229,"Drug"],[231,239,"Drug"],[241,254,"Drug"],[260,272,"Drug"]],"Comments":[]}
{"id":517,"text":"Most of them are substrates of cytochrome P450s (CYPs) and\/or P-glycoprotein (P-gp) [11].","label":[[31,54,"Target"],[62,83,"Target"]],"Comments":[]}
{"id":518,"text":"An important fact is that most of these affected drugs have very narrow therapeutic indices.","label":[],"Comments":[]}
{"id":519,"text":"So, adverse drug reactions, toxicities, and treatment failure are more likely to occur when they are integrated with herbs.","label":[[4,26,"Pathology"],[28,38,"Pathology"]],"Comments":[]}
{"id":520,"text":"To date an increasing number of studies in evaluating HDIs have been reported [11].","label":[],"Comments":[]}
{"id":521,"text":"CYP enzymes can be induced by various herbs.","label":[[0,11,"Target"]],"Comments":[]}
{"id":522,"text":"It was reported that Danshen-Gegen formula (DGF) could induce the liver phase I metabolism of warfarin, especially CYP1A1 and CYP2B1, as a result, it increased the intestinal absorption of warfarin by >30% and decreased its plasma protein binding by >11.6% [12].","label":[[62,102,"Parameter"],[94,102,"Drug"],[115,121,"Target"],[126,132,"Target"],[164,197,"Parameter"],[189,197,"Drug"],[202,205,"Amount"],[224,246,"Parameter"],[251,256,"Amount"]],"Comments":[]}
{"id":523,"text":"A clinic case reported that preadministration of St. John's wort significantly decreased stable plasma level of clozapine from 0.46–0.57 mg\/L to 0.19 mg\/L, after discontinuation of St. John's wort for a month, the clozapine concentration restored to normal [13].","label":[[0,14,"Study"],[49,64,"Herb name"],[89,121,"Parameter"],[112,121,"Drug"],[127,141,"Amount"],[145,154,"Amount"],[181,196,"Herb name"],[197,208,"Duration"],[214,223,"Drug"],[214,237,"Parameter"]],"Comments":[]}
{"id":524,"text":"As the author discussed, St. John's wort may pharmacokinetically interact with clozapine through inducing a number of CYP450 enzymes such as CYP3A4, CYP1A2, CYP2C9, and CYP2C19, which are responsible for clozapine metabolism.","label":[[25,40,"Herb name"],[79,88,"Drug"],[118,132,"Target"],[141,147,"Target"],[149,155,"Target"],[157,163,"Target"],[169,176,"Target"],[204,213,"Drug"]],"Comments":[]}
{"id":525,"text":"In another case it is reported that Ginkgo biloba can negatively influence the effect of antiretroviral drug Efavirenz (EFV) in a HIV infected male patient.","label":[[36,49,"Herb name"],[75,124,"Parameter"],[89,124,"Drug"],[130,133,"Pathology"],[143,147,"Sex"]],"Comments":[]}
{"id":526,"text":"This may due to the inducing effect of Ginkgo biloba on the EFV metabolism enzymes CYP2B6 and CYP3A4 [14].","label":[[39,52,"Herb name"],[60,63,"Drug"],[60,100,"Target"]],"Comments":[]}
{"id":527,"text":"Recently, an in vivo study showed that coadministration of a single dose of baicalin, a Chinese medicine isolated from Scutellaria baicalensis, resulted in a dose-dependent decrease of midazolam in its clearance (CL) from 25% to 34%, while it increased in AUC Most of study reported that HDIs mechanisms are associated with pharmacokinetics and pharmacodynamics related genes, mainly including CYP450 enzymes and\/or P-glycoprotein (P-gp) [11, 17] and also UDP-glucuronosyltransferases (UGTs) [18].","label":[[76,84,"Herb name"],[88,95,"Ethnic group"],[119,142,"Herb name"],[185,194,"Drug"],[202,216,"Parameter"],[221,225,"Amount"],[229,232,"Amount"],[256,259,"Parameter"],[394,408,"Parameter"],[416,437,"Parameter"],[456,491,"Parameter"]],"Comments":[]}
{"id":528,"text":"For more details we can refer to the reviews [11, 19, 20].","label":[],"Comments":[]}
{"id":529,"text":"Some studies found that herb induced expression changes of genes may have some specificity; for instance, it was reported that coadministration of Marsdenia tenacissima extract (MTE) with gefitinib significantly decreased the in vitro intrinsic clearance (Clint) of gefitinib by 2.6- and 4.0-fold for CYP2D6 and CYP3A4, respectively, but did not affect other CYP450s [21]; another study reported that hyperoside could selectively inhibit CYP2D6 activity in a dose dependent manner and might cause herb-drug interactions when coadministrated with CYP2D substrates [22].","label":[[147,182,"Herb name"],[188,197,"Drug"],[226,262,"Parameter"],[266,275,"Drug"],[279,283,"Amount"],[288,296,"Amount"],[301,307,"Target"],[312,318,"Target"],[359,366,"Parameter"],[401,411,"Herb name"],[438,444,"Target"],[546,562,"Parameter"]],"Comments":[]}
{"id":530,"text":"However, whole herbs like garlic, St. John's wort, Gingko, and so forth are complex compounds.","label":[[26,32,"Herb name"],[34,49,"Herb name"],[51,57,"Herb name"]],"Comments":[]}
{"id":531,"text":"Various confounding factors driving the pharmacokinetic profiles of them are considered to be a crucial factor when evaluating HDIs.","label":[],"Comments":[]}
{"id":532,"text":"In these cases we should make sure the confounding factors are at the same levels in the research situations.","label":[],"Comments":[]}
{"id":533,"text":"While evaluating the pharmacokinetic synergy effects of different ingredients in a whole herb on HDIs remains a big challenge so far.","label":[],"Comments":[]}
{"id":534,"text":"Previous studies have made us believe that the genetic involvement in the pharmacokinetic pathways may help us to understand this effect.","label":[],"Comments":[]}
{"id":535,"text":"Recent pharmacogenomics studies in the following and cases listed in Tables 1 and 2 of these pharmacokinetics and pharmacodynamics related genes may help explain the individual differences in HDIs.","label":[[93,144,"Parameter"]],"Comments":[]}
{"id":536,"text":"Genetic polymorphisms have long been studied and believed to involve pharmacokinetic and pharmacodynamic pathways that cause individual difference in drug responses [47].","label":[[0,21,"Parameter"]],"Comments":[]}
{"id":537,"text":"Herbal medicines are actually a combination of potentially biologically active compounds possessing various inherent pharmacological activities.","label":[],"Comments":[]}
{"id":538,"text":"The metabolism of these compounds usually occurs by the same mechanisms as that of drugs.","label":[],"Comments":[]}
{"id":539,"text":"Pharmacokinetic interactions mediated by drug-metabolizing enzymes or transporters are involved in many herb-drug interactions [48], and as the concentrations of the herbal extract and the drug may determine the degree of DHI, polymorphisms in the drug-metabolizing enzyme genes (listed in Table 1) and transporter genes (listed in Table 2) that alter the systemic exposure to the substrate drugs or active components of herbs may affect the risk of interaction [10, 48, 49].","label":[[140,193,"Parameter"],[227,320,"Parameter"],[377,396,"Target"],[400,426,"Target"]],"Comments":[]}
{"id":540,"text":"On the other hand, drug metabolism or transport has alternative pathways.","label":[],"Comments":[]}
{"id":541,"text":"When poor metabolizer genotype or inhibition of an enzyme may lead to the drug metabolized by another pathway enzymes, which may be more sensitive to their native substrates, then it may cause the competition metabolism of drugs or herbs and eventually HDIs difference.","label":[[5,30,"Parameter"]],"Comments":[]}
{"id":542,"text":"So conducting pharmacogenomics studies on HDIs may help to illuminate the fundamental mechanisms underlying the HDIs.","label":[],"Comments":[]}
{"id":543,"text":"In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs.","label":[[30,54,"Study"],[68,80,"Study"]],"Comments":[]}
{"id":544,"text":"St. John's wort is an herb most commonly used for depression and conditions that sometimes go along with depression such as anxiety, tiredness, loss of appetite, and trouble in sleeping.","label":[[0,15,"Herb name"],[50,60,"Pathology"],[105,115,"Pathology"],[124,185,"Pathology"]],"Comments":[]}
{"id":545,"text":"There is some strong scientific evidence that it is effective for mild to moderate depression.","label":[[66,93,"Pathology"]],"Comments":[]}
{"id":546,"text":"Currently it is displayed that 95 drugs (296 brand and generic names) are known to have a major interaction with St. John's wort.","label":[[113,128,"Herb name"]],"Comments":[]}
{"id":547,"text":"After administration of St John's wort, the AUC Ginkgo is often used for memory disorders including Alzheimer's disease.","label":[[23,38,"Herb name"],[44,47,"Parameter"],[48,54,"Herb name"],[73,89,"Pathology"],[100,119,"Pathology"]],"Comments":[]}
{"id":548,"text":"It is also used for conditions that seem to be due to reduced blood flow in the brain, especially in older people.","label":[[54,85,"Pathology"]],"Comments":[]}
{"id":549,"text":"These conditions include memory loss, headache, ringing in the ears, vertigo, difficulty concentrating, mood disturbances, and hearing disorders.","label":[[25,144,"Pathology"]],"Comments":[]}
{"id":550,"text":"Ginkgo enhanced omeprazole hydroxylation in a CYP2C19 genotype-dependent manner.","label":[[0,6,"Herb name"],[16,26,"Drug"],[16,40,"Parameter"],[46,53,"Parameter"]],"Comments":[]}
{"id":551,"text":"The decrease was greater in CYP2C19 PMs ( Baicalin is a flavone glucuronide purified from the medical plant Radix scutellariae through uridine diphosphate glucuronidation.","label":[[28,35,"Parameter"],[42,50,"Herb name"],[108,126,"Herb name"],[135,170,"Parameter"]],"Comments":[]}
{"id":552,"text":"Nowadays, baicalin has begun to be used in bilirubin lowering therapy, both prescribed and over the counter, in China.","label":[[10,18,"Herb name"],[43,52,"Parameter"]],"Comments":[]}
{"id":553,"text":"The mean changes in AUC ratio of bupropion was lower for subjects with CYP2B6 Garlic is widely used around the world for its pungent flavor as a seasoning or condiment.","label":[[20,29,"Parameter"],[33,42,"Drug"],[71,77,"Parameter"],[78,84,"Herb name"]],"Comments":[]}
{"id":554,"text":"There is some scientific evidence that garlic can lower high cholesterol after a few months of treatment.","label":[[39,45,"Herb name"],[61,72,"Parameter"],[79,91,"Duration"]],"Comments":[]}
{"id":555,"text":"Garlic seems to also lower blood pressure in people with high blood pressure and possibly slow “hardening of the arteries.” There is also some evidence that eating garlic might reduce the chance of developing some cancers such as cancer of the colon and possibly stomach cancer and prostate cancer.","label":[[0,6,"Herb name"],[27,41,"Parameter"],[62,76,"Parameter"],[96,121,"Pathology"],[164,170,"Herb name"],[214,221,"Pathology"],[230,249,"Pathology"],[263,277,"Pathology"],[282,297,"Pathology"]],"Comments":[]}
{"id":556,"text":"Coadministration of garlic did not significantly alter warfarin pharmacokinetics or pharmacodynamics.","label":[[20,26,"Herb name"],[55,63,"Drug"]],"Comments":[]}
{"id":557,"text":"However, subjects with the VKORC1 wild-type genotype showed an increase in the S-warfarin EC50 when warfarin was administered with garlic [50].","label":[[27,52,"Parameter"],[79,89,"Drug"],[90,94,"Parameter"],[100,108,"Drug"],[131,137,"Herb name"]],"Comments":[]}
{"id":558,"text":"Grapefruit juice, and grapefruit in general, is a potent inhibitor of the cytochrome P450 CYP3A4 enzyme, which can affect the metabolism of a variety of drugs, increasing their bioavailability.","label":[[0,16,"Extraction process"],[22,32,"Herb name"],[70,103,"Parameter"],[177,192,"Parameter"]],"Comments":[]}
{"id":559,"text":"In some cases, this can lead to a fatal interaction with drugs like astemizole or terfenadine.","label":[[68,78,"Drug"],[82,93,"Drug"]],"Comments":[]}
{"id":560,"text":"Grapefruit juice treatment significantly increased total AUC of lansoprazole in CYP2C19 PMs ( Cranberry juice is the juice of the cranberry.","label":[[0,16,"Extraction process"],[57,60,"Parameter"],[64,76,"Drug"],[80,87,"Parameter"],[94,103,"Herb name"],[104,109,"Extraction process"],[117,122,"Extraction process"],[130,139,"Herb name"]],"Comments":[]}
{"id":561,"text":"Cranberry juice contains phytochemicals, which may help prevent cancer and cardiovascular disease.","label":[[0,9,"Herb name"],[10,15,"Extraction process"],[25,39,"Herb name"],[64,97,"Pathology"]],"Comments":[]}
{"id":562,"text":"Cranberry juice is high in oxalate and has been suggested to increase the risk for developing kidney stones, although more recent studies have indicated it may lower the risk.","label":[[0,9,"Herb name"],[10,15,"Extraction process"],[27,34,"Herb name"],[94,107,"Pathology"]],"Comments":[]}
{"id":563,"text":"Cranberry significantly increased the area under the INR-time curve by 30% when administered with warfarin without altering pharmacokinetics or plasma protein binding of S- or R-warfarin, and this effect is dependent on VKORC11173T>C polymorphism.","label":[[0,9,"Herb name"],[34,67,"Parameter"],[71,74,"Amount"],[98,106,"Drug"],[170,186,"Drug"],[220,246,"Parameter"]],"Comments":[]}
{"id":564,"text":"Subjects with CT and TT genotypes coadministered with cranberry juice extract significantly reduced S-warfarin EC50 (concentration of S-warfarin that produces 50% inhibition of prothrombin complex activity) by 22% and 11%, respectively [50].","label":[[14,33,"Parameter"],[54,77,"Extraction process"],[100,110,"Drug"],[100,115,"Parameter"],[134,144,"Drug"],[159,162,"Amount"],[177,196,"Target"],[177,205,"Parameter"],[210,213,"Amount"],[218,221,"Amount"]],"Comments":[]}
{"id":565,"text":"This case gives us an example of pharmacodynamic pathway gene polymorphisms that can be involved in the herb-drug interaction.","label":[],"Comments":[]}
{"id":566,"text":"Tianqi Jiangtang is an herb widely used for diabetes treatment in China.","label":[[0,16,"Herb name"],[44,52,"Pathology"]],"Comments":[]}
{"id":567,"text":"Tianqi Jiangtang consists of 10 Chinese herbal medicines, namely, Radix Astragali, Radix Trichosanthis, Fructus Ligustri Lucidi, Caulis Dendrobii, Radix Ginseng, Cortex Lycii Radicis bone, Rhizoma Coptidis, Asiatic Cornelian cherry fruit, Ecliptae Herba, and Chinese gall.","label":[[0,16,"Herb name"],[32,39,"Ethnic group"],[66,271,"Herb name"],[259,266,"Ethnic group"]],"Comments":[]}
{"id":568,"text":"Many of these herbal medicines are correlated with diabetes-related parameters.","label":[[51,59,"Pathology"]],"Comments":[]}
{"id":569,"text":"For example, Rhizoma Coptidis and astragalin in Radix Astragali reduce glucose, similar to Diformin.","label":[[13,29,"Herb name"],[34,44,"Herb name"],[48,63,"Herb name"],[71,78,"Parameter"],[91,99,"Drug"]],"Comments":[]}
{"id":570,"text":"Berberine in Rhizoma Coptidis improves some glycemic parameters.","label":[[0,9,"Herb name"],[13,29,"Herb name"],[44,63,"Parameter"]],"Comments":[]}
{"id":571,"text":"Ginsenoside Re in Radix Ginseng has significant antihyperglycemic effects.","label":[[0,14,"Herb name"],[18,31,"Herb name"],[48,65,"Pathology"]],"Comments":[]}
{"id":572,"text":"The iridocytes of Cornus officinalis in Asiatic Cornelian cherry fruit prevent diabetic vascular complications.","label":[[0,36,"Herb name"],[40,47,"Ethnic group"],[40,64,"Herb name"],[65,70,"Herb part"],[79,110,"Pathology"]],"Comments":[]}
{"id":573,"text":"Only one major effective component of Tianqi Jiangtang has been identified, namely, berberine hydrochloride (C A total of 194 impaired glucose tolerance (IGT) subjects treated with Tianqi Jiangtang for 12 months were genotyped for 184 mutations in 34 genes involved in drug metabolism or transportation.","label":[[38,54,"Herb name"],[84,107,"Herb name"],[122,167,"Cohort"],[126,158,"Pathology"],[135,152,"Parameter"],[181,197,"Herb name"],[198,211,"Duration"],[231,234,"Amount"],[235,244,"Parameter"],[248,250,"Amount"],[251,302,"Parameter"]],"Comments":[]}
{"id":574,"text":"The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene was significantly associated with the hypoglycemic effect of the drug (P = 0.001, FDR P = 0.043).","label":[[0,73,"Parameter"],[112,124,"Pathology"]],"Comments":[]}
{"id":575,"text":"The “G” allele frequencies of rs1142345 in the healthy (subjects reverted from IGT to normal glucose tolerance), maintenance (subjects still had IGT), and deterioration (subjects progressed from IGT to T2D) groups were 0.094, 0.214, and 0.542, respectively.","label":[[0,39,"Parameter"],[47,54,"Pathology"],[79,82,"Pathology"],[93,110,"Parameter"],[145,148,"Pathology"],[195,198,"Pathology"],[202,205,"Pathology"],[219,224,"Amount"],[226,231,"Amount"],[237,242,"Amount"]],"Comments":[]}
{"id":576,"text":"Rs1142345 was also significantly associated with the hypoglycemic effect of the drug between the healthy and maintenance groups (P = 0.027, OR = 4.828) and between the healthy and deterioration groups (P = 0.001, OR = 7.811).","label":[[0,9,"Parameter"],[53,65,"Pathology"],[97,104,"Pathology"],[168,175,"Pathology"]],"Comments":[]}
{"id":577,"text":"Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs.","label":[[11,20,"Parameter"],[76,88,"Pathology"]],"Comments":[]}
{"id":578,"text":"This is the first study to utilize the ADME gene chip in the pharmacogenetic study of traditional herbs [35].","label":[],"Comments":[]}
{"id":579,"text":"Due to the limitations of conventional drugs, the use of herbal medicinal products (HMPs) as a CAM integrated with drugs for treatment has been increasing, this eventually will contribute to a rising incidence of herb-drug interactions.","label":[[57,89,"Herb name"]],"Comments":[]}
{"id":580,"text":"However, because of variability in herbal product composition, uncertainty of the causative constituents, and often scant knowledge of causative constituent pharmacokinetics, the mechanisms underlie herb-drug interactions remain an understudied area, and evaluation of herbal product interaction liability is still a big challenge [19].","label":[],"Comments":[]}
{"id":581,"text":"Studies showed that these HDIs are mediated mainly by metabolism enzymes and transporters in the pharmacokinetic pathways.","label":[[54,89,"Parameter"]],"Comments":[]}
{"id":582,"text":"Polymorphisms in these pharmacokinetic pathways related genes can contribute to the individual difference of HDIs effect.","label":[[0,13,"Parameter"]],"Comments":[]}
{"id":583,"text":"We make an updated review with respect to pharmacogenomics related HDIs on some important herb products and call for a vigilance of using these drug for therapy when the patient is taking medication with narrow therapeutic indices.","label":[],"Comments":[]}
{"id":584,"text":"Currently, there is still a lack of effective method to predict HDIs in the clinic; the main obstacles are laid by the multiconstituents of an herb.","label":[],"Comments":[]}
{"id":585,"text":"In the near future years, scientist in this area should focus on identifying individual constituents from herbal products, characterizing pharmacokinetics and pharmacodynamics of each individual constituents, discovering the fundamental genetic bases that eventually facilitate prospective identification of herb-drug interactions.","label":[[106,121,"Herb name"]],"Comments":[]}
{"id":586,"text":"Here we reviewed a definite involvement of pharmacogenomics in HDIs; some other mechanism, such as epigenetic regulations, that is, a recent hotspot area, is also supposed to take part in it.","label":[],"Comments":[]}
{"id":587,"text":"The National Institute of Health (NIH) and similar organizations in other countries have increased the financial support for scientific investigation on safety use of herb medicines.","label":[],"Comments":[]}
{"id":588,"text":"This trend will promote the herb medicines more normalization as that of drugs, and the progress may promote finding new effective drugs from extracts of herbs.","label":[],"Comments":[]}
{"id":589,"text":"With respect to the wide and increasing use of herb drugs and their benefits, and with the progress in pharmacogenomics and pharm-chemistry, we are still optimistic on this area.","label":[],"Comments":[]}
{"id":590,"text":"This work was supported by the National Scientific Foundation of China (nos.","label":[],"Comments":[]}
{"id":591,"text":"81273595 and 81373489) and the National High Technology Research and Development Program of China, “863” Project (no.","label":[],"Comments":[]}
{"id":592,"text":"2012AA02A517 and no.","label":[],"Comments":[]}
{"id":593,"text":"2012AA02A518).","label":[],"Comments":[]}
{"id":594,"text":"The authors declare no conflict of interests.","label":[],"Comments":[]}
{"id":595,"text":"Metabolic enzyme gene polymorphisms and HDIs.","label":[[0,35,"Parameter"]],"Comments":[]}
{"id":596,"text":"AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer.","label":[[0,29,"Parameter"]],"Comments":[]}
{"id":597,"text":"Transporter gene polymorphisms and HDIs.","label":[[0,30,"Parameter"]],"Comments":[]}
